Medicinal Product Shortages - update - 2 November 2023

Notice type: Advisory

Date: 02/11/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

 

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Atecor 50mg Tablets

 

PA0711/003/002

 

Rowex Ltd

Atenolol

Bendamustine HCl 100 mg Powder

for Concentrate for Solution for

Infusion

 

PA2059/028/002

 

Fresenius Kabi Deutschland GmbH

Bendamustine

CONBRIZA 20 mg Film Coated

Tablets]

 

EU/1/09/511/001

 

Pfizer Europe MA EEIG

 

Bazedoxifene

Daktarin 2% w/w Cutaneous

Powder

 

PA0330/048/002

 

Johnson & Johnson (Ireland)

Limited

 

Miconazole

Dermovate 0.05% w/w Cream

 

PA1077/005/001

 

GlaxoSmithKline (Ireland) Limited

 

Clobetasol

Donepezil Krka 5mg Film Coated

Tablets

 

PA1347/014/003

 

KRKA, d.d., Novo mesto

 

Donepezil

Estradot 100mcg/24 hours,

Transdermal Patch

 

PA0896/010/004

 

Novartis Ireland Limited

 

Estradiol

Ezetimibe Krka 10mg Tablets

 

PA1347/066/001

 

KRKA, d.d., Novo mesto

Ezetimibe

Fental Matrix 25 micrograms/hour

Transdermal Patch

 

PA0711/146/001

 

Rowex Ltd

 

Fentanyl

Flucloxacillin 1000mg Powder for

solution for injection/infusion

 

PA1862/003/003

 

Ibigen Srl

Flucloxacillin

Fortum 1g Powder for Solution for

Injection or Infusion

 

PA23311/001/002

 

Sandoz Pharmaceuticals d.d.

Ceftazidime

Lioresal 5mg/5ml Oral solution

 

PA0896/017/002

 

Novartis Ireland Limited

 

Baclofen

Lithium Chloride 0.15 mmol/ml.

Solution for Injection

 

PA23039/001/001

 

LiDCO Netherlands B.V

Lithium

Mivacron 2mg/ml Solution for Injection

 

(5ml presentation only)

 

PA1691/031/001

 

Aspen Pharma Trading Limited

Mivacurium

Montelukast Mylan 4mg Chewable

Tablets

 

PA0577/131/001

 

McDermott Laboratories Ltd., T/A

Gerard Laboratories

 

Montelukast

Norditropin FlexPro 15mg/1.5 ml,

Solution for Injection

 

PA0218/040/013

 

Novo Nordisk A/S

 

Norditropin

Olanzapine Teva 10mg

Orodispersible Tablet

 

EU/1/07/427/027

 

Teva B.V.

Olanzapine

Omeprazole Teva 10mg Gastro-Resistant Capsules

 

PA0749/160/001

 

Teva Pharma B.V.

Omeprazole

Optiray 350 mg I/ml solution for

injection or infusion

(500ml)

PA0686/007/006

Guerbet

 

Ioversol

Requip 0.25 mg Film Coated Tablets

 

PA1077/037/001

 

GlaxoSmithKline (Ireland) Limited

 

Ropinirole

Rhinolast 140 micrograms per

Spray, Nasal Spray

 

PA2010/037/001

 

Mylan IRE Healthcare Limited

Azelastine

Valsartan Krka 80mg Film Coated

Tablets

 

PA1347/010/007

 

KRKA, d.d., Novo mesto

Valsartan

Valsartan Mylan 80mg Film Coated Tablets

 

PA0577/134/002

 

McDermott Laboratories Ltd., T/A

Gerard Laboratories

 

Valsartan

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Amlodipine Teva 10mg Tablets

 

PA0749/067/002

 

Teva Pharma B.V.

Amlodipine

ARICEPT 5mg Film Coated Tablets

 

PA0822/002/001

Pfizer Healthcare Ireland

Donepezil

Atecor 100mg Tablets

 

PA0711/003/003

 

Rowex Ltd

Atenolol

Bendamustine 25mg Powder for Concentrate for Solution for Infusion

 

PA1986/121/001

 

Teva B.V.

Bendamustine

Carboplatin-Teva 10mg/ml Concentrate for Solution for Infusion

 

(600mg presentation)

 

PA0749/004/001

 

Teva Pharma B.V.

Carboplatin

Co-amoxiclav 1000mg/200mg Powder for Solution for Injection/Infusion

 

PA2220/002/002

 

Instituto Biochimico Italiano G. Lorenzini S.p.A.

Amoxicillin & clavulanic acid

Crystapen 600mg Powder for Solution for Injection or Infusion

 

PA0126/313/001

 

Clonmel Healthcare Ltd

Benzylpenicillin

Drynol 20mg Tablets

 

PA0865/018/001

 

Menarini International Operations Luxembourg S.A.

Bilastine

Ezetimibe Rowa 10mg Tablets

 

PA0074/074/001

 

Rowa Pharmaceuticals Limited

Ezetimibe

Foznol 750mg Chewable Tablets

 

PA23211/002/003

 

Takeda Pharmaceuticals International AG Ireland Branch

Lanthanum

Fucidin 20 mg/g Cream

 

PA0046/004/012

 

Leo Laboratories Limited

Fusidic acid

Fucithalmic 10mg/g Viscous Eye Drops, Suspension

 

PA1142/016/001

 

Amdipharm Limited

Fusidic acid

INSPRA 25mg Film Coated Tablets

 

PA23055/005/001

 

Upjohn EESV

Eplerenone

Lansoprazole Teva Pharma 15mg Gastro-resistant Capsules, Hard

 

PA1986/008/001

 

Teva B.V.

Lansoprazole

Ritalin LA 30mg prolonged-release capsules

 

PA1972/002/003

 

InfectoPharm Arzneimittel und Consilium GmbH

Methylphenidate

NASONEX 50 micrograms/actuation Nasal Spray, Suspension

 

PA23198/011/001

 

Organon Pharma (Ireland) Limited

Mometasone

Neurostil 300mg Capsules, Hard

 

PA0749/164/002

 

Teva Pharma B.V.

Gabapentin

Rosuvastatin Krka 5mg Film Coated Tablets

 

PA1347/016/001

 

KRKA, d.d., Novo mesto

Rosuvastatin

Rosuvastatin Krka 20mg Film Coated Tablets

 

PA1347/016/003

 

KRKA, d.d., Novo mesto

Rosuvastatin

 

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 



« Back